期刊文献+

玻璃酸钠与维固力联合应用治疗膝骨关节炎体会 被引量:1

下载PDF
导出
摘要 骨关节炎(OA)是一种慢性关节进行性退变、软骨下骨质增生的骨关节疾病,临床以关节疼痛、变形和活动受限为特点,所引起的功能障碍是老年人致残及生活质量下降的主要原因之一,其发病机制尚不完全清楚,一般认为与衰老、创伤、炎症、肥胖、代谢障碍、免疫异常和遗传等多方面因素有关。
出处 《医学信息》 2011年第3期947-948,共2页 Journal of Medical Information
  • 相关文献

参考文献5

  • 1Leslie M. Hyaluronic aid treatment for osteoarthritis of theknee [J]. Nurse Pratt, 1999,24 : 38,41-48.
  • 2骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796. 被引量:1966
  • 3许鹏,王效东,郭雄.透明质酸与骨关节炎[J].中华风湿病学杂志,2002,6(5):360-363. 被引量:52
  • 4Schenck P ,Schneider S,M ichlke S,et al.Synthesis anddegradation of hyaluronate by Synovh from patien- widl rheumatoid a-aritis 13.R.heumatol, 1995,22(2) : 400.
  • 5Neo H ,Ishimara J l,Kurta K,et al.The efect of hyalurorfic acid on experimental temporomandibular joint ostcoarthrosis in the ship Ⅱ .J Oral Maxill ofac Sury, 1977 55(10): 1114.

二级参考文献23

  • 1Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 2Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 3Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 5Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 6Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.
  • 7Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669.
  • 8Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944.
  • 9Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681.
  • 10Chevalier X, Marre JP, de Butler J, et al. Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol, 2004, 22: 205-212.

共引文献2016

同被引文献21

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部